New Enterprise Associates closes a $3.6B fund, focused on tech and healthcare startups at all stages, bringing its total capital under management to $24B
Jonathan Shieber / TechCrunch :
Context & Ripple Effects
This is the third consecutive record-scale raise in New Enterprise Associates' own arc: after the $3.1B fund in 2015 and the $3.3B fund that was then the largest venture fund ever, the firm is back with $3.6B, pushing total capital under management to $24B. The all-stages mandate matters — it puts NEA in direct competition with multi-stage peers like a16z and Accel rather than just seed specialists.
First-order effects
- NEA's portfolio companies in tech and healthcare gain access to larger checks at every stage from a single investor, while limited partners have just committed fresh capital to a firm already holding $24B under management.
Second-order effects
- Rivals are locked into the same arms race — a16z's $4.5B pair of funds, Bessemer's $3.3B close, and Accel's $4B global late-stage fund show every major firm scaling up to defend deal access, intensifying competition for both breakout startups and finite LP commitments.
Third-order effects
- Capital keeps concentrating in a handful of multi-stage giants, and NEA's reported plan to sell stakes in roughly 20 startups worth about $1B signals that secondary sales are becoming a standard liquidity tool when IPO windows narrow — reshaping how these mega-funds recycle capital.
The trend: Venture capital is consolidating into ever-larger multi-stage funds, with firms like NEA, a16z, and Accel raising successive record vehicles and turning secondaries into a routine exit valve.